Tag: Sight Diagnostics

[Sight Diagnostics in PR Newswire] AA Pharma Strengthens its Support of Canadian Clozapine Patients With Exclusive Rights to Blood Analyzer

TORONTO, April 27, 2021 /CNW/ – AA Pharma, a Canadian company focused on legacy pharmaceutical products, has secured the exclusive Canadian rights for the use of a blood analyzer for patients prescribed Clozapine. This medication, indicated for patients with Treatment Resistant Schizophrenia, requires regular blood monitoring. Read more...

Read More

[Sight Diagnostics in CTech] Israel’s Sight Diagnostics’ Sight OLO deployed at Oxford University’s John Radcliffe Hospital

Sight Diagnostics, an Israeli company that delivers lab-grade Full Blood Count (FBC) results in just a few minutes, has deployed its Sight OLO solution at the John Radcliffe Hospital, part of Oxford University Hospitals NHS Foundation. The deployment means that patients who attend the emergency departments have access to quick FBC testing as part of a rapid AI triage system for Covid-19. Read more...

Read More

Latest from Twitter